» Articles » PMID: 30459211

Absence of Functional Compensation Between Coagulation Factor VIII and Plasminogen in Double-knockout Mice

Overview
Journal Blood Adv
Specialty Hematology
Date 2018 Nov 22
PMID 30459211
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Plasminogen deficiency is associated with severely compromised fibrinolysis and extravascular deposition of fibrin. In contrast, coagulation factor VIII (FVIII) deficiency leads to prolonged and excessive bleeding. Based on opposing biological functions of plasminogen and FVIII deficiencies, we hypothesized that genetic elimination of FVIII would alleviate the systemic formation of fibrin deposits associated with plasminogen deficiency and, in turn, elimination of plasminogen would limit bleeding symptoms associated with FVIII deficiency. Mice with single and combined deficiencies of FVIII (F8) and plasminogen (Plg) were evaluated for phenotypic characteristics of plasminogen deficiency, including wasting disease, shortened lifespan, rectal prolapse, and multiorgan fibrin deposition. Conversely, to specifically examine the role of plasmin-mediated fibrinolysis on bleeding caused by FVIII deficiency, F8 and F8/Plg mice were subjected to a bleeding challenge. Mice with a combined deficiency in FVIII and plasminogen displayed no phenotypic differences relative to mice with single FVIII or plasminogen deficiency. Plg and F8/Plg mice exhibited the same penetrance and severity of wasting disease, rectal prolapse, extravascular fibrin deposits, and reduced viability. Furthermore, following a tail vein-bleeding challenge, no significant differences in bleeding times or total blood loss could be detected between F8 and F8/Plg mice. Moreover, F8 and F8/Plg mice responded similarly to recombinant FVIII (rFVIII) therapy. In summary, the pathological phenotype of Plg mice developed independently of FVIII-dependent coagulation, and elimination of plasmin-driven fibrinolysis did not play a significant role in a nonmucosal bleeding model in hemophilia A mice.

Citing Articles

Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A.

Strilchuk A, Hur W, Batty P, Sang Y, Abrahams S, Yong A Sci Transl Med. 2024; 16(735):eadh0027.

PMID: 38381848 PMC: 11293256. DOI: 10.1126/scitranslmed.adh0027.


Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation.

Hur W, Paul D, Bouck E, Negron O, Mwiza J, Poole L Blood. 2021; 139(9):1374-1388.

PMID: 34905618 PMC: 8900273. DOI: 10.1182/blood.2021012537.


Plasminogen Deficiency and Amiloride Mitigate Angiotensin II-Induced Hypertension in Type 1 Diabetic Mice Suggesting Effects Through the Epithelial Sodium Channel.

Andersen H, Hansen M, Buhl K, Staehr M, Friis U, Enggaard C J Am Heart Assoc. 2020; 9(23):e016387.

PMID: 33215566 PMC: 7763785. DOI: 10.1161/JAHA.120.016387.


Bleeding is increased in amyloid precursor protein knockout mouse.

Mazinani N, Strilchuk A, Baylis J, Hur W, Jefferies W, Kastrup C Res Pract Thromb Haemost. 2020; 4(5):823-828.

PMID: 32685890 PMC: 7354397. DOI: 10.1002/rth2.12375.


Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency.

Strilchuk A, Meixner S, Leung J, Safikhan N, Kulkarni J, Russell H Blood. 2020; 136(25):2946-2954.

PMID: 32678423 PMC: 9710420. DOI: 10.1182/blood.2020004976.

References
1.
Bugge T, Flick M, Danton M, Daugherty C, Romer J, Dano K . Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci U S A. 1996; 93(12):5899-904. PMC: 39159. DOI: 10.1073/pnas.93.12.5899. View

2.
Cole H, Ohba T, Nyman J, Hirotaka H, Cates J, Flick M . Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice. Arthritis Rheumatol. 2014; 66(8):2222-33. PMC: 4474376. DOI: 10.1002/art.38639. View

3.
Ghosh K, Shetty S, Jijina F, Mohanty D . Role of epsilon amino caproic acid in the management of haemophilic patients with inhibitors. Haemophilia. 2004; 10(1):58-62. DOI: 10.1046/j.1351-8216.2003.00839.x. View

4.
Le D, Borgs P, Toneff T, Witte M, RAPAPORT S . Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. Am J Physiol. 1998; 274(3):H769-76. DOI: 10.1152/ajpheart.1998.274.3.H769. View

5.
Yang Y, Carmeliet P, Hamilton J . Tissue-type plasminogen activator deficiency exacerbates arthritis. J Immunol. 2001; 167(2):1047-52. DOI: 10.4049/jimmunol.167.2.1047. View